Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CRISPR
CRISPR
Intellia's CRISPR-engineered cell therapy secures FDA orphan drug status after AML trial launch
Fierce Biotech
Wed, 03/9/22 - 11:13 pm
Intellia Therapeutics
CRISPR
FDA
cell therapy
orphan drugs
Intellia presses forward with new results for pioneering CRISPR drug
BioPharma Dive
Mon, 02/28/22 - 11:46 pm
Intellia Therapeutics
CRISPR
transthyretin amyloidosis
Drugs based on next-generation gene editing are moving toward the clinic faster than CRISPR 1.0
Stat
Thu, 02/10/22 - 10:25 am
CRISPR
gene editing
Jennifer Doudna
Bayer jumps on board Mammoth's ultra-small CRISPR tech with sights set first on liver disease
Endpoints
Mon, 01/10/22 - 11:28 am
Bayer
CRISPR
Jennifer Doudna
Mammoth Biosciences
First sickle cell patient treated with CRISPR gene-editing still thriving
NPR
Fri, 12/31/21 - 11:07 am
CRISPR
gene editing
sickle cell disease
Using CRISPR to find a new drug target for multiple sclerosis, inflammatory bowel disease
Fierce Biotech
Sun, 11/14/21 - 10:52 pm
CRISPR
gene editing
Vanderbilt
multiple sclerosis
allergies
IBD
Exavir Aims CRISPR Program at HIV, Sees Powerful Preclinical Results
BioSpace
Wed, 11/10/21 - 10:47 am
HIV
Exavir Therapeutics
gene editing
CRISPR
CRISPR-editing biotech Arbor Bio adds $215M for liver, CNS disease therapies
MedCity News
Wed, 11/10/21 - 10:17 am
Arbor Biotechnologies
MIT
liver disease
CNS disorders
funding
CRISPR
Moderna finally cracks into gene editing with Metagenomi pact thanks to 'irresistible' data
Fierce Biotech
Tue, 11/2/21 - 10:46 am
Moderna Therapeutics
gene editing
CRISPR
Metagenomi
Editas' gene-editing data has company touting prime time based on early vision improvement signals but questions remain
Fierce Biotech
Wed, 09/29/21 - 11:12 am
CRISPR
Editas Medicine
gene editing
EDIT-101
vision loss
FDA Approves First Human Trial for Potential CRISPR-Led HIV Cure
BioSpace
Thu, 09/16/21 - 10:36 pm
FDA
CRISPR
HIV
EBT-101
Excision BioTherapeutics
clinical trials
FDA clears first-of-its-kind trial to see if CRISPR gene editing can cure HIV
Endpoints
Wed, 09/15/21 - 10:26 pm
Excision BioTherapeutics
CRISPR
clinical trials
HIV
gene editing
Mammoth Bio’s massive $195M financing makes the CRISPR company a unicorn
MedCity News
Thu, 09/9/21 - 10:55 am
Mammoth Biosciences
CRISPR
diagnostics
Why Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR Therapeutics
Motley Fool
Mon, 09/6/21 - 09:03 pm
Vertex Pharmaceuticals
CRISPR
gene editing
Arbor Biotechnologies
Vertex boosts cell and genetic therapies toolkit in deal worth up to $1.2bn with Arbor
Biopharma Reporter
Mon, 08/30/21 - 10:57 am
Vertex
cell therapy
gene therapy
CRISPR
gene editing
Arbor Biotechnologies
New CRISPR-Based Rapid COVID-19 Test Can Detect SARS-CoV-2 Variants
Xtalks
Tue, 08/10/21 - 10:33 am
CRISPR
diagnostics
COVID-19
Caribou raises $304M in one of gene editing's most lucrative IPOs
BioPharma Dive
Sat, 07/24/21 - 06:34 pm
Caribou Biosciences
CRISPR
gene editing
IPOs
Jennifer Doudna Reacts to Intellia CRISPR Breakthrough, Outlines Challenges
BioSpace
Fri, 07/2/21 - 11:01 am
Jennifer Doudna
CRISPR
Intellia Therapeutics
Hitting landmark milestone, Intellia shows CRISPR can edit genes directly in patients
Endpoints
Sun, 06/27/21 - 12:03 am
Intellia
gene editing
CRISPR
Vertex puts a blockbuster valuation on its CRISPR deal
EP Vantage
Tue, 04/20/21 - 11:05 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
CTX001
M&A
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »